Table of Contents
ISRN Neurology
Volume 2011, Article ID 590249, 7 pages
http://dx.doi.org/10.5402/2011/590249
Review Article

Ion Channels in Glioblastoma

Department of Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105 AZ Amsterdam, The Netherlands

Received 4 August 2011; Accepted 19 September 2011

Academic Editors: A. Gambardella, J. A. Rey, and R. Yamanaka

Copyright © 2011 Remco J. Molenaar. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. N. Louis, H. Ohgaki, O. D. Wiestler et al., “The 2007 WHO classification of tumours of the central nervous system,” Acta Neuropathologica, vol. 114, no. 2, pp. 97–109, 2007. View at Publisher · View at Google Scholar
  2. H. Ohgaki and P. Kleihues, “Genetic pathways to primary and secondary glioblastoma,” American Journal of Pathology, vol. 170, no. 5, pp. 1445–1453, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Stupp, W. P. Mason, M. J. Van Den Bent et al., “Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma,” New England Journal of Medicine, vol. 352, no. 10, pp. 987–996, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. D. W. Parsons, S. Jones, X. Zhang et al., “An integrated genomic analysis of human glioblastoma multiforme,” Science, vol. 321, no. 5897, pp. 1807–1812, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Verkhratsky and C. Steinhäuser, “Ion channels in glial cells,” Brain Research Reviews, vol. 32, no. 2-3, pp. 380–412, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. D. J. Blackiston, K. A. McLaughlin, and M. Levin, “Bioelectric controls of cell proliferation: ion channels, membrane voltage and the cell cycle,” Cell Cycle, vol. 8, no. 21, pp. 3519–3528, 2009. View at Google Scholar · View at Scopus
  7. A. K. Weaver, X. Liu, and H. Sontheimer, “Role for calcium-activated potassium channels (BK) in growth control of human malignant glioma cells,” Journal of Neuroscience Research, vol. 78, no. 2, pp. 224–234, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Ishiuchi, K. Tsuzuki, Y. Yoshida et al., “Blockage of Ca2+-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells,” Nature Medicine, vol. 8, no. 9, pp. 971–978, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. V. C. H. Lui, S. S. S. Lung, J. K. S. Pu, K. N. Hung, and G. K. K. Leung, “Invasion of human glioma cells is regulated by multiple chloride channels including ClC-3,” Anticancer Research, vol. 30, no. 11, pp. 4515–4524, 2010. View at Google Scholar · View at Scopus
  10. L. Soroceanu, T. J. Manning Jr., and H. Sontheimer, “Modulation of glioma cell migration and invasion using Cl- and K+ ion channel blockers,” Journal of Neuroscience, vol. 19, no. 14, pp. 5942–5954, 1999. View at Google Scholar · View at Scopus
  11. R. Wondergem and J. W. Bartley, “Menthol increases human glioblastoma intracellular Ca2+, BK channel activity and cell migration,” Journal of Biomedical Science, vol. 16, no. 1, article no. 90, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Wondergem, T. W. Ecay, F. Mahieu, G. Owsianik, and B. Nilius, “HGF/SF and menthol increase human glioblastoma cell calcium and migration,” Biochemical and Biophysical Research Communications, vol. 372, no. 1, pp. 210–215, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. S. S. Kang, K. S. Han, B. M. Ku et al., “Caffeine-mediated inhibition of calcium release channel inositol 1,4,5-trisphosphate receptor subtype 3 blocks glioblastoma invasion and extends survival,” Cancer Research, vol. 70, no. 3, pp. 1173–1183, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Basrai, R. Kraft, C. Bollensdorff, L. Liebmann, K. Benndorf, and S. Patt, “BK channel blockers inhibit potassium-induced proliferation of human astrocytoma cells,” NeuroReport, vol. 13, no. 4, pp. 403–407, 2002. View at Google Scholar · View at Scopus
  15. A. K. Weaver, V. C. Bomben, and H. Sontheimer, “Expression and function of calcium-activated potassium channels in human glioma cells,” GLIA, vol. 54, no. 3, pp. 223–233, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. C. B. Ransom and H. Sontheimer, “BK channels in human glioma cells,” Journal of Neurophysiology, vol. 85, no. 2, pp. 790–803, 2001. View at Google Scholar
  17. C. B. Ransom, X. Liu, and H. Sontheimer, “BK channels in human glioma cells have enhanced calcium sensitivity,” GLIA, vol. 38, no. 4, pp. 281–291, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. X. Liu, Y. Chang, P. H. Reinhart, and H. Sontheimer, “Cloning and characterization of glioma BK, a novel BK channel isoform highly expressed in human glioma cells,” Journal of Neuroscience, vol. 22, no. 5, pp. 1840–1849, 2002. View at Google Scholar · View at Scopus
  19. I. F. Abdullaev, A. Rudkouskaya, A. A. Mongin, and Y. H. Kuo, “Calcium-activated potassium channels BK and IK1 are functionally expressed in human gliomas but do not regulate cell proliferation,” PLoS One, vol. 5, no. 8, Article ID e12304, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. A. K. Weaver, M. L. Olsen, M. B. McFerrin, and H. Sontheimer, “BK channels are linked to inositol 1,4,5-triphosphate receptors via lipid rafts: a novel mechanism for coupling [Ca2+]i to ion channel activation,” Journal of Biological Chemistry, vol. 282, no. 43, pp. 31558–31568, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Bordey and H. Sontheimer, “Electrophysiological properties of human astrocytic tumor cells in situ: enigma of spiking glial cells,” Journal of Neurophysiology, vol. 79, no. 5, pp. 2782–2793, 1998. View at Google Scholar · View at Scopus
  22. E. A. Newman, “Inward-rectifying potassium channels in retinal glial (Muller) cells,” Journal of Neuroscience, vol. 13, no. 8, pp. 3333–3345, 1993. View at Google Scholar · View at Scopus
  23. M. L. Olsen and H. Sontheimer, “Mislocalization of Kir channels in malignant glia,” GLIA, vol. 46, no. 1, pp. 63–73, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. R. K. Orkand, J. G. Nicholls, and S. W. Kuffler, “Effect of nerve impulses on the membrane potential of glial cells in the central nervous system of amphibia,” Journal of Neurophysiology, vol. 29, no. 4, pp. 788–806, 1966. View at Google Scholar · View at Scopus
  25. S. F. Traynelis and R. Dingledine, “Potassium-induced spontaneous electrographic seizures in the rat hippocampal slice,” Journal of Neurophysiology, vol. 59, no. 1, pp. 259–276, 1988. View at Google Scholar · View at Scopus
  26. Z. C. Ye and H. Sontheimer, “Glioma cells release excitotoxic concentrations of glutamate,” Cancer Research, vol. 59, no. 17, pp. 4383–4391, 1999. View at Google Scholar · View at Scopus
  27. S. Patt, K. Preußat, C. Beetz et al., “Expression of ether à go-go potassium channels in human gliomas,” Neuroscience Letters, vol. 368, no. 3, pp. 249–253, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Masi, A. Becchetti, R. Restano-Cassulini et al., “hERG1 channels are overexpressed in glioblastoma multiforme and modulate VEGF secretion in glioblastoma cell lines,” British Journal of Cancer, vol. 93, no. 7, pp. 781–792, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. E. Lastraioli, L. Guasti, O. Crociani et al., “herg1 gene and HERG1 protein are overexpressed in colorectal cancers and regulate cell invasion of tumor cells,” Cancer Research, vol. 64, no. 2, pp. 606–611, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Cherubini, G. L. Taddei, O. Crociani et al., “HERG potassium channels are more frequently expressed in human endometrial cancer as compared to non-cancerous endometrium,” British Journal of Cancer, vol. 83, no. 12, pp. 1722–1729, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Pillozzi, M. F. Brizzi, M. Balzi et al., “HERG potassium channels are constitutively expressed in primary human acute myeloid leukemias and regulate cell proliferation of normal and leukemic hemopoietic progenitors,” Leukemia, vol. 16, no. 9, pp. 1791–1798, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Godard, G. Getz, M. Delorenzi et al., “Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes,” Cancer Research, vol. 63, no. 20, pp. 6613–6625, 2003. View at Google Scholar · View at Scopus
  33. M. L. Olsen, S. Schade, S. A. Lyons, M. D. Amaral, and H. Sontheimer, “Expression of voltage-gated chloride channels in human glioma cells,” Journal of Neuroscience, vol. 23, no. 13, pp. 5572–5582, 2003. View at Google Scholar · View at Scopus
  34. B. Fioretti, E. Castigli, I. Calzuola, A. A. Harper, F. Franciolini, and L. Catacuzzeno, “NPPB block of the intermediate-conductance Ca2+-activated K+ channel,” European Journal of Pharmacology, vol. 497, no. 1, pp. 1–6, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. V. A. Cuddapah and H. Sontheimer, “Molecular interaction and functional regulation of ClC-3 by Ca2+/calmodulin-dependent protein kinase II (CaMKII) in human malignant glioma,” Journal of Biological Chemistry, vol. 285, no. 15, pp. 11188–11196, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Bordey, H. Sontheimer, and J. Trouslard, “Muscarinic activation of BK channels induces membrane oscillations in glioma cells and leads to inhibition of cell migration,” Journal of Membrane Biology, vol. 176, no. 1, pp. 31–40, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. IARC, Agents Classified by the IARC Monographs, vol. 1–102, IARC, 2011.
  38. X. Ding, Z. He, K. Zhou et al., “Essential role of trpc6 channels in G2/M phase transition and development of human glioma,” Journal of the National Cancer Institute, vol. 102, no. 14, pp. 1052–1068, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. A. D. Joshi, D. W. Parsons, V. E. Velculescu, and G. J. Riggins, “Sodium ion channel mutations in glioblastoma patients correlate with shorter survival,” Molecular Cancer, vol. 10, article 17, 2011. View at Publisher · View at Google Scholar
  40. H. Yan, D. W. Parsons, G. Jin et al., “IDH1 and IDH2 mutations in gliomas,” New England Journal of Medicine, vol. 360, no. 8, pp. 765–773, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. G. G. Goldin and A. R. Safa, “Digitalis and cancer,” Lancet, vol. 1, no. 8386, p. 1134, 1984. View at Google Scholar · View at Scopus
  42. T. Mijatovic, E. Van Quaquebeke, B. Delest, O. Debeir, F. Darro, and R. Kiss, “Cardiotonic steroids on the road to anti-cancer therapy,” Biochimica et Biophysica Acta, vol. 1776, no. 1, pp. 32–57, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. J. K. T. Wang, S. Portbury, M. B. Thomas et al., “Cardiac glycosides provide neuroprotection against ischemic stroke: discovery by a brain slice-based compound screening platform,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 27, pp. 10461–10466, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. J. K. Bubien, D. A. Keeton, C. M. Fuller et al., “Malignant human gliomas express an amiloride-sensitive Na+ conductance,” American Journal of Physiology, vol. 276, no. 6, pp. C1405–C1410, 1999. View at Google Scholar · View at Scopus
  45. J. K. Bubien, H. L. Ji, G. Y. Gillespie et al., “Cation selectivity and inhibition of malignant glioma Na+ channels by Psalmotoxin 1,” American Journal of Physiology, vol. 287, no. 5, pp. C1282–C1291, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. Chen and S. H. Tseng, “The potential of tetrandrine against gliomas,” Anti-Cancer Agents in Medicinal Chemistry, vol. 10, no. 7, pp. 534–542, 2010. View at Google Scholar · View at Scopus
  47. Y. Chen, J. C. Chen, and S. H. Tseng, “Tetrandrine suppresses tumor growth and angiogenesis of gliomas in rats,” International Journal of Cancer, vol. 124, no. 10, pp. 2260–2269, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. R. G. W. Verhaak, K. A. Hoadley, E. Purdom et al., “Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1,” Cancer Cell, vol. 17, no. 1, pp. 98–110, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. N. S. Ningaraj, U. T. Sankpal, D. Khaitan, E. A. Meister, and T. Vats, “Activation of KATP channels increases anticancer drug delivery to brain tumors and survival,” European Journal of Pharmacology, vol. 602, no. 2-3, pp. 188–193, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Li, J. Walling, Y. Kotliarov et al., “Genomic changes and gene expression profiles reveal that established glioma cell lines are poorly representative of primary human gliomas,” Molecular Cancer Research, vol. 6, no. 1, pp. 21–30, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. J. Clarke, N. Butowski, and S. Chang, “Recent advances in therapy for glioblastoma,” Archives of Neurology, vol. 67, no. 3, pp. 279–283, 2010. View at Publisher · View at Google Scholar · View at Scopus